After four decades managing patients with septic shock, I have become increasingly concerned about a fundamental question in contemporary resuscitation: Are we placing too much emphasis on lactate normalization while overlooking the complex physiology of tissue perfusion?

Serum lactate has become one of the most influential biomarkers in critical care medicine. It informs risk stratification, contributes to sepsis recognition, and frequently influences therapeutic decisions.

But lactate is not a direct measurement of tissue oxygenation, and its elevation does not invariably indicate inadequate oxygen delivery.

The distinction is far more than academic. It has important implications for fluid administration, vasopressor titration, and the management of patients with persistent hyperlactatemia despite apparently adequate macrocirculatory resuscitation.

The Biochemistry of Hyperlactatemia Is More Complicated Than We Acknowledge

Historically, elevated lactate concentrations were frequently interpreted as evidence of anaerobic metabolism resulting from impaired tissue oxygen delivery.

Certainly, when oxygen delivery falls below a critical threshold, oxygen consumption becomes supply-dependent, and lactate accumulation may accompany cellular dysoxia.

However, septic hyperlactatemia involves several additional mechanisms.

Adrenergic stimulation can accelerate aerobic glycolysis through beta-2 receptor-mediated activation of the sodium-potassium ATPase, increasing pyruvate production beyond the oxidative capacity of the mitochondria.

Altered pyruvate dehydrogenase activity, mitochondrial dysfunction, impaired hepatic lactate clearance, and changes in regional microcirculatory blood flow may further contribute.

Consequently, elevated lactate concentrations can persist even when global oxygen delivery appears sufficient. Hepatic function is also a factor.

This raises an important clinical question: If lactate elevation does not necessarily indicate ongoing oxygen debt, should its normalization always remain our principal resuscitation objective?

Macrohemodynamic Stability Does Not Guarantee Microcirculatory Recovery

One of the defining challenges in septic shock is the dissociation between macrocirculatory parameters and microvascular perfusion.

We may achieve a mean arterial pressure of 65 mmHg or greater, restore an acceptable cardiac output, and observe improvement in central venous oxygen saturation while substantial microcirculatory abnormalities persist.

Sepsis-associated endothelial dysfunction, glycocalyx degradation, heterogeneous capillary perfusion, leukocyte adhesion, and microvascular shunting can impair effective oxygen extraction.

The result is a patient whose systemic hemodynamic measurements appear reassuring while cellular oxygen utilization remains compromised.

Blood pressure targets will not fix this and should be individualized. Bulk oxygen delivery is certainly more important but does not address these issues either. Finally lactate measurements can only include perfused tissue. All require our attention, but tissue and cellular “respiration” are more complex.

It also underscores the limitations of relying upon a single biochemical marker to determine whether resuscitation has been successful.

The Potential Consequences of Lactate-Driven Over-Resuscitation

When lactate remains elevated, clinicians may feel compelled to administer additional intravenous fluids, escalate vasopressors, or introduce inotropic support.

These interventions can be appropriate when supported by evidence of persistent hypoperfusion.

But they are not physiologically benign.

Excessive fluid administration may increase venous pressures, worsen interstitial edema with its own impact on cellular oxygenation, impair pulmonary gas exchange, and contribute to renal venous congestion.

Elevated central venous pressure can reduce the effective perfusion gradient across vulnerable organs, particularly when accompanied by increased intra-abdominal pressure or right ventricular dysfunction, both common in the patients we treat.

Similarly, indiscriminate escalation of catecholamines may increase myocardial oxygen consumption, precipitate tachyarrhythmias, and aggravate regional perfusion abnormalities.

We must distinguish persistent hyperlactatemia from persistent fluid-responsive circulatory failure.

They are not synonymous.

Functional Hemodynamics Should Guide Our Decisions

Throughout my clinical and academic career, I have emphasized the importance of understanding the physiologic response to treatment rather than relying exclusively on static measurements.

Fluid responsiveness, for example, should be evaluated using appropriate dynamic assessments when their underlying assumptions are satisfied.

Passive leg raising with real-time stroke volume measurement, pulse pressure variation under suitable ventilatory conditions, and echocardiographic assessment of ventricular function can provide valuable information.

However, fluid responsiveness does not automatically establish fluid requirement.

A patient may demonstrate an increase in stroke volume following preload augmentation while simultaneously having substantial pulmonary edema or elevated venous filling pressures.

The decision to administer fluid must integrate both potential hemodynamic benefit and the risk of further congestion.

This is particularly important in patients with sepsis-associated cardiomyopathy, acute respiratory distress syndrome, or preexisting ventricular dysfunction.

Should Peripheral Perfusion Receive Greater Attention?

Capillary refill time, skin temperature gradients, mottling, urine output, and bedside echocardiography offer complementary perspectives on circulatory adequacy.

Clinical trials comparing peripheral perfusion-targeted strategies with lactate-targeted approaches have challenged the assumption that lactate-guided resuscitation should dominate every phase of septic shock management.

These findings do not suggest abandoning lactate measurement.

Rather, they support integrating biochemical trends with bedside physiology and clinical judgement.

Treat the Physiology, Not the Laboratory Value

The future of septic shock management lies in individualized physiologic assessment.

The objective should be to identify the mechanisms responsible for circulatory dysfunction, determine which abnormalities are treatable, and avoid interventions that introduce more harm than benefit.

Our responsibility as intensivists is not merely to correct numbers. It is to understand the physiology producing those numbers—and to intervene when doing so is likely to improve the patient's outcome.